Atricure, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Atricure, Inc. on May 24, 2007. The filing discloses the entry into a Material Definitive Agreement and the unregistered sale of equity securities. The company is incorporated in Delaware and headquartered in West Chester, Ohio.
Key Financial Metrics
The filing details a private placement financing transaction with the following metrics:
- Gross Proceeds: $16.5 million
- Net Proceeds: Approximately $15.2 million (after deducting a 6% placement agent fee and transaction expenses)
- Shares Issued: 1,789,649 shares of common stock
- Share Pricing:
- 1,683,060 shares sold at $9.15 per share
- 106,589 shares sold to an entity affiliated with a director at $10.32 per share (closing bid price on May 23, 2007)
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity positions outside of this specific transaction.
Material Changes
The primary material change is the increase in equity capital and the dilution of existing shareholders due to the issuance of 1,789,649 new shares. The transaction is expected to close on or about May 30, 2007, subject to customary closing conditions.
Outlook, Management Commentary, and Risks
Use of Proceeds: Net proceeds will be used for working capital, general corporate purposes, research and development activities, and potential acquisitions or other strategic initiatives.
Registration Rights: Atricure entered into a Registration Rights Agreement requiring the filing of a Registration Statement for the resale of shares within 30 calendar days of closing. The company must use reasonable best efforts to have the statement declared effective by the SEC no later than 90 days after closing (or 120 days if the SEC issues written comments).
Risks and Contingencies:
- Penalties: Failure to file the Registration Statement timely or have it declared effective within specified periods will result in penalty payments to the purchasers.
- Restrictions: The shares are restricted securities and may not be offered or sold in the U.S. without registration or an applicable exemption.
- Investor Status: All investors represented they are "accredited investors" under Rule 501(a) of Regulation D.
Key Facts for Investor Verification
- Verify the actual closing date of the transaction (expected May 30, 2007) and confirmation of the $15.2 million net proceeds.
- Monitor the filing of the Registration Statement for resale of shares and its subsequent effectiveness date to avoid potential penalty payments by the company.
- Review the specific terms of the Securities Purchase Agreement (Exhibit 10.1) and Registration Rights Agreement (Exhibit 10.2) for detailed penalty structures and covenants.
- Confirm the allocation of funds between working capital, R&D, and potential acquisitions as the transaction closes.